# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Nikola Tesla (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI009-SYN-TD
- Date: 1902-01-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Branimir Kovač-Holt, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week sertraline tolerability and safety check; psychiatry consultation today. **S**

## History of present illness

Mr. Tesla returns two weeks after starting sertraline 50 mg each morning. He had mild nausea for four days and looser stools, now settled, and no headache, restlessness, or change in sleep. He has missed no doses. He has had his first session of exposure and response prevention and began building his list of feared situations. He still washes his hands about 50 times a day, but uses the ointment after each wash and the cracks are less painful. He has eaten two meals a day most days. He has had no suicidal thoughts. He saw Dr. Feinberg-Osei of psychiatry this morning. **S**

| Element | Detail |
|---|---|
| Medication tolerance | Mild nausea and loose stools for four days, now settled |
| Adherence | No missed doses |
| Rituals | Washing about 50 times a day; counting and calculating unchanged |
| Psychotherapy | First ERP session; hierarchy started |
| Safety | No suicidal thoughts |
| Y-BOCS | 27, down from 28 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Negative | Early nausea settled; eating two meals most days |
| Integumentary | Positive | Hand cracks less painful |
| Neurological | Negative | No headache or tremor |
| Psychiatric | Positive | Obsessions and rituals unchanged; no suicidal thoughts, elevated mood, or racing thoughts |

4 systems reviewed. **S**

## Current medications

- Sertraline 50 mg oral tablet, one tablet by mouth each morning **S**
- White petrolatum ointment, apply to both hands after each wash and at bedtime **S**

## Allergies

- No known allergy **S**

## Objective

BP 114/70 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 63.9 kg; BMI 18.1 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Tall, thin, immaculately dressed; washed his hands on arrival, which was offered |
| Skin | Examined without touch at his request: dry, red skin over the backs of both hands with fewer and shallower fissures than two weeks ago |
| Mental status | Formal and precise; mood "the same, but hopeful"; affect anxious; obsessions with good insight; no hallucinations or delusions; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Obsessive-compulsive disorder, severe** (F42.2). Y-BOCS 27, down from 28 after two weeks, which is expected this early. Sertraline is well tolerated. Psychiatry confirms OCD with good insight and finds no tic disorder, bipolar disorder, psychosis, or obsessive-compulsive personality disorder. Suicide risk is low. **S**
   - Continue sertraline 50 mg; if the response is inadequate at six weeks, increase in 50 mg steps every four to six weeks as tolerated, as Dr. Feinberg-Osei advised.
   - Weekly ERP; homework from the hierarchy.
   - Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.
2. **Irritant hand dermatitis** (L24.9). Improving with petrolatum. **S**
   - Continue petrolatum after each wash and cotton gloves at night.
3. **Underweight from food rituals** (R63.6). Weight steady at 63.9 kg. **S**
   - Dietitian visit next week; three fixed mealtimes.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Y-BOCS severity score (recorded in the note; no LOINC code found) | At baseline and about every 4 to 6 weeks during acute treatment | Completed today | 27, down from 28 at intake |
| Survey | Comorbidity review: tics, bipolar disorder, psychosis, hoarding, body dysmorphic symptoms, and personality | At the initial assessment | Completed today | Psychiatric interview today found none of these; depressive and anxiety symptoms are secondary to the OCD |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given) | Every visit during acute treatment | Completed today | No suicidal thoughts, intent, plan, or behavior since intake. Protective factors unchanged. Safety plan reviewed |
| Medication safety | Sertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects) | Every visit and two weeks after each dose increase | Completed today | Early nausea and loose stools settled; no activation; no missed doses; dose unchanged at 50 mg |
| Self-management | Exposure and response prevention attendance and homework | Every visit during acute treatment | Completed today | First session done; hierarchy started |
| Examination | Weight and BMI | Every visit while underweight | Completed today | 63.9 kg, BMI 18.1, steady |
| Examination | Hand skin | Every visit while dermatitis is present | Completed today | Fewer and shallower fissures |
| Referral | Psychiatry consultation | For severe OCD at the start of treatment | Completed today | Seen today; diagnosis confirmed; titration plan agreed |
| Medication safety | Antipsychotic augmentation monitoring (weight, glucose, lipids, movement) | Only if an antipsychotic is added | Not indicated | No augmentation; responding to sertraline and ERP |

## Goal progress

- Y-BOCS down by at least 35 percent (treatment response) by twenty-four weeks. In progress; target 1902-06-30. **S**
- Rituals under one hour a day, with meals eaten without calculating. In progress; target 1902-06-30. **S**
- BMI at least 18.5 with three meals a day. In progress; target 1902-06-30. **S**
- Hands healed, with washing under 15 times a day. In progress; target 1902-04-07. **S**
- At least six hours of sleep most nights. In progress; target 1902-06-30. **S**

## Guideline basis

- Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007), American Psychiatric Association
- Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013), American Psychiatric Association
- Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005), National Institute for Health and Care Excellence
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Review in four weeks, six weeks after starting sertraline. **S**
- Next scheduled visit 1902-02-24: six-week OCD treatment review. **S**
